Sign In
Buy VCEL
$34.74
+0.290 (+0.84%)
At Close: Jun 03, 2026
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
02:39pm, Saturday, 30'th May 2026
Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.
Vericel Q1 Earnings Call Highlights
02:10am, Saturday, 09'th May 2026
Vericel NASDAQ: VCEL reported record first-quarter revenue and raised its full-year 2026 outlook, citing strong growth across its MACI cartilage repair franchise and Burn Care business, as well as exp
Vericel Corporation (VCEL) Q1 2026 Earnings Call Transcript
11:31pm, Thursday, 07'th May 2026
Vericel Corporation (VCEL) Q1 2026 Earnings Call Transcript
Vericel Corporation (VCEL) Reports Q1 Loss, Beats Revenue Estimates
12:16pm, Thursday, 07'th May 2026
Vericel Corporation (VCEL) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.23 per share a year ago.
Vericel Reports First Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
07:45am, Thursday, 07'th May 2026
Total Revenue Increased 30% to $68.4 Million, with MACI Revenue Growth of 22% and Burn Care Revenue Growth of 91%
Wall Street Analysts Think Vericel (VCEL) Could Surge 53.42%: Read This Before Placing a Bet
10:56am, Monday, 04'th May 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 53.4% in Vericel (VCEL). While the effectiveness of this highly sought-after metric is questionable, the positi
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
08:30am, Thursday, 23'rd Apr 2026
CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Co
Aberdeen Group plc Has $21.03 Million Stock Position in Vericel Corporation $VCEL
03:07am, Monday, 06'th Apr 2026
Aberdeen Group plc boosted its holdings in Vericel Corporation (NASDAQ: VCEL) by 7.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional
Analysts Set Vericel Corporation (NASDAQ:VCEL) Price Target at $56.00
01:40am, Monday, 06'th Apr 2026
Shares of Vericel Corporation (NASDAQ: VCEL - Get Free Report) have earned an average rating of "Moderate Buy" from the eight brokerages that are covering the firm, Marketbeat reports. Three equities
Vericel Announces BARDA Award Valued at up to $197 Million for Procurement and Advanced Development of NexoBrid
02:40pm, Thursday, 02'nd Apr 2026
CAMBRIDGE, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, has been awarded a ten-year
Vericel Corporation $VCEL Position Increased by Congress Asset Management Co.
01:39pm, Tuesday, 24'th Mar 2026
Congress Asset Management Co. grew its holdings in shares of Vericel Corporation (NASDAQ: VCEL) by 11.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm
Intech Investment Management LLC Decreases Stock Holdings in Vericel Corporation $VCEL
05:01am, Monday, 09'th Mar 2026
Intech Investment Management LLC decreased its stake in shares of Vericel Corporation (NASDAQ: VCEL) by 42.8% during the third quarter, according to the company in its most recent Form 13F filing with
Vericel Corporation (VCEL) Matches Q4 Earnings Estimates
01:21pm, Thursday, 26'th Feb 2026
Vericel Corporation (VCEL) came out with quarterly earnings of $0.45 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.38 per share a year ago.
Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript
12:58pm, Thursday, 26'th Feb 2026
Vericel Corporation (VCEL) Q4 2025 Earnings Call Transcript
Vericel Reports Fourth Quarter and Full-Year 2025 Financial Results
07:55am, Thursday, 26'th Feb 2026
Total Revenue of $276.3 Million, with MACI Revenue Growth of 21% to $239.5 Million Net Income Growth of 59% to $16.5 Million Fourth Quarter Total Revenue and MACI Revenue Growth of 23% Record Fourth Q
